| Entry |
|
|---|
| Name |
Inamrinone (USP);
Amrinone (JAN/INN);
Amcoral (TN) |
|---|
| Formula |
C10H9N3O
|
|---|
| Exact mass |
187.0746
|
|---|
| Mol weight |
187.198
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01703 Cardiotonic
DG01757 Amrinone type cardiotonic
DG01507 Phosphodiesterase III inhibitor
DG01757 Amrinone type cardiotonic
|
|---|
| Remark |
|
|---|
| Efficacy |
Cardiotonic, Phosphodiesterase 3 inhibitor |
|---|
| Comment |
Amrinone derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CE Phosphodiesterase inhibitors
C01CE01 Amrinone
D00231 Inamrinone (USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01757 Amrinone type cardiotonic
DG00228 Amrinone
D00231 Inamrinone
DG01507 Phosphodiesterase III inhibitor
DG01757 Amrinone type cardiotonic
DG00228 Amrinone
D00231 Inamrinone
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE3
D00231 Inamrinone (USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01757 Amrinone type cardiotonic
DG00228 Amrinone
DG01507 Phosphodiesterase III inhibitor
DG01757 Amrinone type cardiotonic
DG00228 Amrinone
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 14
1 C8y C 18.8920 -16.7926
2 C8y C 20.1271 -16.1237
3 C8x C 17.6932 -16.0675
4 C8x C 18.8666 -18.1940
5 C8x C 20.1866 -14.7238
6 C8x C 21.3057 -16.8729
7 C8y C 16.4687 -16.7440
8 N4x N 17.6342 -18.8681
9 C8x C 21.4195 -14.0760
10 C8x C 22.6167 -16.2273
11 C8y C 16.4406 -18.1402
12 N1a N 15.2699 -16.0189
13 N5x N 22.6061 -14.8276
14 O5x O 15.2163 -18.8166
BOND 15
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 2 6 2
6 3 7 2
7 4 8 1
8 5 9 2
9 6 10 1
10 7 11 1
11 7 12 1
12 9 13 1
13 11 14 2
14 8 11 1
15 10 13 2
|
|---|
